New radiation therapy shows promise for Tough-to-Treat prostate cancer

NCT ID NCT05720130

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new treatment called [212Pb]Pb-ADVC001 for men with prostate cancer that has spread to other parts of the body. The treatment delivers a small amount of radiation directly to cancer cells. The study has two parts: first, finding the safest and most effective dose, and then testing that dose in a larger group of 100 participants to see if it can shrink tumors and slow the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gold Coast University Hospital

    RECRUITING

    Southport, Queensland, 4215, Australia

    Contact

  • Princess Alexandra Hospital

    RECRUITING

    Brisbane, Queensland, 4102, Australia

    Contact

  • Royal Brisbane & Women's Hospital

    RECRUITING

    Brisbane, Queensland, 4029, Australia

    Contact